Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
Lobbying on Behalf of Sanofi US
Names of Lobbyists
Firm Hired Amount Sanofi-Aventis $7,900,000
Most Frequently Disclosed Lobbying Issues
- Health Issues,
- Medicare & Medicaid,
- Copyright, Patent & Trademark,
- Medical Research & Clin Labs,
- Economics & Econ Development,
- Fed Budget & Appropriations,
Most Frequently Disclosed Bills
Bill No. Title H.RES.295 Promoting increased awareness, diagnosis, and treatment of atrial fibrillation to address the high morbidity and mortality rates and to prevent avoidable hospitalizations associated with this disease. H.R.942 American Research and Competitiveness Act of 2011 S.1884 School Access to Emergency Epinephrine Act H.R.3627 School Access to Emergency Epinephrine Act S.1577 Greater Research Opportunities With Tax Help Act H.R.5910 Global Investment in American Jobs Act of 2012 S.27 Preserve Access to Affordable Generics Act S.3274 Global Investment in American Jobs Act of 2012 S.3187 Food and Drug Administration Safety and Innovation Act S.RES.243 A resolution promoting increased awareness, diagnosis, and treatment of atrial fibrillation to address the high morbidity and mortality rates and to prevent avoidable hospitalizations associated with the disease.
RegulationsMentioned in 1 docket
All data is based on documents downloaded from Regulations.gov. The first table shows mentions: all documents that include the name of the company anywhere in the document or document metadata. The second table shows submissions: all documents where the submitter metadata included the company name. Each table shows the top 10 dockets, ranked by number of occurrences.
Matches are based on a search for the company name. Variations in the company name, such as acronyms, nicknames or alternate names may cause documents to be missed. The mention of a company name in a document may be incidental and does not necessarily indicate that the company has any relevance to the document. Company names that are common English words may erroneously match with text that is not referring to the company.
Not all agencies submit public comments to Regulations.gov. For a list of participating and non-participating agencies see here. Agencies that do submit to Regulations.gov have varying levels of accuracy and completeness.
Regulations and public comments can be downloaded in bulk here.
The tables show occurrences of "Sanofi US" in public comments on proposed federal regulations.
Mentions in Document Text
View all mentions data for Sanofi US